Cameron Todd, MD
Otolaryngology · Colorado Springs, CONPI 1972065548
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Cochlear Americas accounts for 61.9% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $3,323, more than ten times the $34 reported in 2023.
Across 53 payments — averaging $74.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cochlear Americas$2K
- Inspire Medical Systems, Inc.$487
- GSK$308
- Preceptis Medical, Inc.$196
- AstraZeneca$136
- Medtronic$115
- plus $269 from 6 others
What the payments were for
- Consulting fees$1,80045%
- Travel & lodging$3198%
- Food & beverage$1,85047%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cochlear Americas | 15 | $2,457 |
| Inspire Medical Systems, Inc. | 9 | $487 |
| GSK | 14 | $308 |
| Preceptis Medical, Inc. | 1 | $196 |
| AstraZeneca | 2 | $136 |
| Medtronic | 2 | $115 |
| Advanced Bionics, LLC | 3 | $106 |
| Stryker | 3 | $70 |
| Neurent Medical Limited | 1 | $30 |
| Smith+Nephew | 1 | $26 |
| Optinose US, Inc. | 1 | $21 |
| Itamar Medical Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode$2,159
- Baha$2,159
- OSIA OSI300 IMPLANT$2,159
- Inspire$149
- NUCALA$122
- TEZSPIRE$110
- LigaSure$101
How this compares
$3,969 in reported general payments places this provider in the 85th percentile of 174 otolaryngology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 11 | $72 |
| Tramadol Hcl | 12 | $14 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Colorado Springs
- Barton KnoxColorado Springs$164K
- Nicholas BeckmannColorado Springs$151K
- Michael WilhelmColorado Springs$76K
- Robert KellerColorado Springs$45K
- David BookColorado Springs$5K
- Edgar GallowayColorado Springs$5K
- Jonathan ArnholtColorado Springs$4K
- Elycia Kazemian-MarviColorado Springs$4K
- Matthew WhineryColorado Springs$3K
- Jennifer ReavisColorado Springs$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.